Updated Date: Wed, 01 Dec 2021 00:00:00 EST
Category: Uncategorized
In a late-stage clinical trial, the biologic agent dupilumab reduced the rate of severe asthma attacks and improved […]
We are one of the most medicated generations of humans to live on our planet. Cardiometabolic diseases like […]
As end of New York opioid trial nears, AbbVie’s Allergan ponies up $200M to settle its part of […]
AstraZeneca’s COVID therapy becomes first antibody approved for immunocompromised people preexposure
AstraZeneca’s COVID therapy becomes first antibody approved for immunocompromised people preexposure kdunleavy Wed, 12/08/2021 – 17:40
While chronic traumatic encephalopathy (CTE) cannot yet be diagnosed during life, a new study provides the best evidence […]
Using artificial intelligence, a team of University at Buffalo researchers has developed a novel system that models the […]
With an official death toll that has just surpassed five million, the covid-19 global crisis is on a […]
A senior official at the World Health Organisation (WHO) has said that Omicron is ‘highly unlikely’ to fully […]
